Erika Hamilton: Check out our new practice LinkedIn page

Erika Hamilton shared a post by SCRI Oncology Partners on LinkedIn, adding:

”Check out our new practice LinkedIn page!

We are so excited to have a robust clinical trial menu through Sarah Cannon Research Institute to give patients more options in Nashville!

Give us a follow below!”

Quoting SCRI Oncology Partners’s post:

”SCRI Oncology Partners were so happy to be able to offer this Sarah Cannon Research Institute trial to their patients facing metastatic ER + breast cancer.

Now published in Annals of Oncology. Applause to the patient volunteers that made this possible.

SERDs degrade the estrogen receptor that causes cancer growth in ER + tumors. Promising new class of drugs!”

Source: Erika Hamilton/LinkedIn and SCRI Oncology Partners/LinkedIn

Erika Hamilton is a medical oncologist and the Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute (USA). In her role, Dr. Hamilton oversees the research program and clinical trial menu for gynecologic and breast cancer from a medical oncology perspective. Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee a ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee. She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.